Russia faces shortage of drugs against Parkinson's disease

Russian patients with Parkinson's disease have faced a shortage of life-saving drugs based on levodopa, as, according to latest data of the Russian analyst agency RNC Pharma, the supply of these drugs has decreased by 49% in a year. At the same time, according to representatives of various Russian patient communities, approximately 300,000 out of 350,000 Russians, living with Parkinson's disease, need levodopa daily, reports The Pharma Letter’s local correspondent.

So far, representatives of Movement - Life" Fund, a public fund helping and assisting people with Parkinson's disease, has sent more than 400 letters to the Russian Parliament with a request to pay attention to the catastrophic situation with drugs, which contain an active ingredient levodopa + benserazide.

The reason of such shortage is due to the disappearance of a number of such drugs from the market in recent months.